A detailed history of Essex LLC transactions in Xencor Inc stock. As of the latest transaction made, Essex LLC holds 132,661 shares of XNCR stock, worth $2.74 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
132,661
Holding current value
$2.74 Million
% of portfolio
0.55%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$15.7 - $21.65 $2.08 Million - $2.87 Million
132,661 New
132,661 $2.67 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Essex LLC Portfolio

Follow Essex LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.